Mary Hayden to Staphylococcus aureus
This is a "connection" page, showing publications Mary Hayden has written about Staphylococcus aureus.
Connection Strength
0.498
-
Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2005 Oct; 43(10):5285-7.
Score: 0.245
-
Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol. 2007 Jun; 45(6):1705-11.
Score: 0.068
-
Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs: A Randomized Clinical Trial. JAMA. 2023 10 10; 330(14):1337-1347.
Score: 0.053
-
Development of a Broth Microdilution Method To Characterize Chlorhexidine MICs among Bacteria Collected from 2005 to 2019 at Three U.S. Sites. Microbiol Spectr. 2023 06 15; 11(3):e0413422.
Score: 0.052
-
Clonal features of community-acquired methicillin-resistant Staphylococcus aureus in children. Clin Infect Dis. 2000 Mar; 30(3):630-1.
Score: 0.042
-
Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial. Lancet. 2019 Mar 23; 393(10177):1205-1215.
Score: 0.039